← Back to all articles
PharmacologyPubMed Verified

Immunological modulation and control of parasitaemia by ayahuasca compounds: therapeutic potential for Chagas disease

Katchborian-Neto A, Santos MFC, Vilas-Boas DF, Dos Santos EG, Veloso MP, Bueno PCP, Caldas IS, Soares MG, Dias DF, Chagas-Paula DA

Parasitology Research (2023)

Preclinical in vitro/in vivo
Abstract

Investigated ayahuasca compounds' antiparasitic potential against Trypanosoma cruzi (Chagas disease). Harmine and DMT showed immunomodulatory effects and reduced parasitaemia in animal models. First evidence of ayahuasca alkaloids' anti-parasitic properties, opening a novel therapeutic avenue.

Citations5
Study TypePreclinical in vitro/in vivo
Chagas diseaseTrypanosoma cruziantiparasiticimmunomodulationharmine
DOI: 10.1007/s00436-023-07884-8View on PubMed

Related Articles

Pharmacology

Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells

Salles G, de Carvalho Alves I et al.

Archives of Toxicology, 2025
Pharmacology

Development of a physiologically based pharmacokinetic model of N,N-dimethyltryptamine, harmine, and their interactions from ayahuasca in rats and humans

Wittayakarn N, Tan YM et al.

Toxicological Sciences, 2025
Pharmacology

Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial

Mueller MJ, Aicher HD et al.

International Journal of Neuropsychopharmacology, 2024
Pharmacology

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

Aicher HD, Mueller MJ et al.

Frontiers in Psychiatry, 2024